Tech Company Financing Transactions

SynGen Funding Round

SynGen closed a $5 million Series A investment round on 4/20/2012. Investors included Bay City Capital.

Transaction Overview

Company Name
Announced On
4/20/2012
Transaction Type
Venture Equity
Amount
$5,000,000
Round
Series A
Investors

Bay City Capital (Carl Goldfoscher)

Proceeds Purpose
We will use these proceeds to accelerate the commercialization of our SynGen-1000 platform product.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
2711 Citrus Rd.
Rancho Cordova, CA 95742
USA
Email Address
Overview
At SynGen Inc. we develop advanced cell separation tools and accessories, applying innovative design to aid regenerative medicine workflows.
Profile
SynGen LinkedIn Company Profile
Social Media
SynGen Company Twitter Account
Company News
SynGen News
Facebook
SynGen on Facebook
YouTube
SynGen on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Chris Xu
  Chris Xu LinkedIn Profile  Chris Xu Twitter Account  Chris Xu News  Chris Xu on Facebook
Chief Technical Officer
Philip Coelho
  Philip Coelho LinkedIn Profile  Philip Coelho Twitter Account  Philip Coelho News  Philip Coelho on Facebook
VP - General Counsel
James Xu
  James Xu LinkedIn Profile  James Xu Twitter Account  James Xu News  James Xu on Facebook


 

 

Browse more venture capital transactions:

Prev: 4/20/2012: Neighborland venture capital transaction
Next: 4/20/2012: Lifecrowd venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to record every notable VC transaction. VC investment data records reported here are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary